298 Feasibility study of concurrent cisplatin/etoposide (PE) and thoracic radiotherapy (TRT) followed by weekly dose intensive regimen (CODE) with human granulocyte-colony stimulating factor (G-CSF) for limited stage (LS) small cell lung cancer (SCLC): Report of a Japan clinical oncology group study (JCOG-9509)
Kubota, K.; Nishiwaki, Y.; Furuse, K.; Fukuoka, M.; Takada, M.; Ariyoshi, Y.; Kurita, Y.; Saijo, N.
- 期刊名称Lung Cancer
- 作者Kubota, K.; Nishiwaki, Y.; Furuse, K.; Fukuoka, M.; Takada, M.; Ariyoshi, Y.; Kurita, Y.; Saijo, N.
- 卷第18卷
- 印刷ISSN0169-5002
- 文件大小153.76KB
- 发表时间1997-8
- DOI10.1016/S0169-5002(97)89683-3